Latest Research Trends (17 Jan 2025)

Delivery of Prime editing in human stem cells

Journal: Nature Communications

Author: Thibaut Halegua et al., France

Novel NanoScribes particle system enables efficient prime editing in human stem cells.

Development of virus-like particles for delivering prime editing components achieves up to 68% editing efficiency in HEK293T cells and 25% in stem cells.

Comprehensive genomic characterization of early-stage bladder cancer

Journal: Nature Genetics

Author: Frederik Prip et. al, Denmark

Multi-omics analysis reveals genomic instability patterns in non-muscle invasive bladder cancer.

The study analyzed 438 NMIBC cases using multi-omics approach, identifying WGD in 15% of tumors linked to poor outcomes and revealing key roles of genomic instability in disease progression.

ABCF1-K430-Lactylation in HCC”

Journal: Cell Death & Differentiation

Author: Han Hong et. al, China

Novel lactylation mechanism of ABCF1 promotes liver cancer progression through HIF1 pathway

Study identifies ABCF1-K430la as prognostic marker in HCC, revealing its role in cancer progression through KDM3A-H3K9me2-HIF1A axis activation and identifying tubuloside A as potential therapeutic.

Intratumoral mRNA vaccine administration

Journal: Cell Discovery

Author: Renhao Li et. al, China

Novel cancer immunotherapy strategy using intratumoral mRNA vaccines leverages existing pathogen immunity.

This researchs uses the innovative approach of the COVID-19 vaccine technology for cancer treatment, showing promising results in solid tumors, particularly effective when combined with anti-PD-L1 therapy.

Subscribe to the latest updates in the newsletter

Share your disease area, therapeutic candidate and research objectives.

Related Solutions

Organoid Service
Research Service
Technical Service

ODISEI CNS - Human brain & retinal organoid
solutions for translational CNS discovery.

Please provide the information below, and our team will contact you shortly with brochure and relevant case studies.

Thank you for your submission.

Our team has received your request and will get back to you shortly.
If you do not receive our confirmation email, kindly check your spam or junk folder.